In clear cell renal cell carcinoma29 and in bladder cancer ZNF154 is hypermethylated, and ZNF154 methylation is identified as a biomarker of bladder cancer recurrence30, 31. The gene discussed is ZNF154; the disease is urinary bladder cancer.